Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13744521 | 0.84 | ALDH1A1 (0.46) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL27009949 | 0.82 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL14410125 | 0.80 | ALDH1A1 (0.46) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL16589158 | 0.80 | ALDH1A1 (0.46) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL954244 | 0.80 | ALDH1A1 (0.46) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL14707472 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL13770870 | 0.78 | ALDH1A1 (0.43) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL14134173 | 0.77 | ALDH1A1 (0.41) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL12307730 | 0.77 | ALDH1A1 (0.41) | ALDH1A1KDM4ELMNARAB9AKMT2A | |
| SCHEMBL14133970 | 0.76 | ALDH1A1 (0.38) | ALDH1A1KDM4ELMNARAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8709704-B2 | Pattern forming method using developer containing organic solvent and rinsing solution for use in the pattern forming method | FUJIFILM CORPORATION (JP) | 2014-04-29 | — | — | US | disclosed |
| US-20120322007-A1 | PATTERN FORMING METHOD, CHEMICAL AMPLIFICATION RESIST COMPOSITION AND RESIST FILM | FUJIFILM CORPORATION (JP) | 2012-12-20 | — | — | US | disclosed |
| US-20120056249-A1 | INTERLAYER FOR ELECTRONIC DEVICES | PROMERUS LLC (US) | 2012-03-08 | — | — | US | disclosed |
| WO-2012028278-A1 | INTERLAYER FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | WO | disclosed |
| WO-2012028279-A1 | GATE INSULATOR LAYER FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | WO | disclosed |
| US-20120056183-A1 | GATE INSULATOR LAYER FOR ORGANIC ELECTRONIC DEVICES | PROMERUS LLC (US) | 2012-03-08 | — | — | US | disclosed |
| US-20110229832-A1 | PATTERN FORMING METHOD USING DEVELOPER CONTAINING ORGANIC SOLVENT AND RINSING SOLUTION FOR USE IN THE PATTERN FORMING METHOD | FUJIFILM CORPORATION (JP) | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110229832-A1 | PATTERN FORMING METHOD USING DEVELOPER CONTAINING ORGANIC SOLVENT AND RINSING SOLUTION FOR USE IN THE PATTERN FORMING METHOD | RER1, RARA, RARG | ALDH1A1 1783/4885KDM4E 3329/4885LMNA 3661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.